SCHEMBL27779103

SCHEMBL27779103

Cn1c(=O)c(-c2cc(NC(=O)Nc3cccc(C(F)(F)F)c3)c(F)cc2CN)cc2cnc(N)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 5/20 0.43
PDGFRA P16234 2/20 0.43
SRC P12931 4/20 0.43
LCK P06239 4/20 0.43
FLT1 P17948 4/20 0.43
LYN P07948 4/20 0.43
FYN P06241 3/20 0.43
CSF1R P07333 3/20 0.43
FLT4 P35916 3/20 0.43
BLK P51451 3/20 0.43
SYK P43405 3/20 0.43
NTRK1 P04629 2/20 0.43
NTRK2 Q16620 2/20 0.43
FGFR1 P11362 2/20 0.43
JAK3 P52333 2/20 0.43
PTK2 Q05397 2/20 0.43
DYRK3 O43781 1/20 0.43
JAK2 O60674 1/20 0.43
ROCK2 O75116 1/20 0.43
MAP4K4 O95819 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4425440 0.90 SYK (0.47) KITPDGFRASRCLCKFLT1
SCHEMBL8233709 0.83 KIT (0.49) KITPDGFRASRCLCKSYK
SCHEMBL28783643 0.83 KIT (0.57) KITPDGFRASRCLCKFLT1
SCHEMBL28783703 0.82 KIT (0.67) KITPDGFRASRCLYNMEN1
SCHEMBL4419801 0.80 KIT (0.55) KITPDGFRASRCLCKSYK
SCHEMBL5061396 0.79 KIT (0.54) KITPDGFRASRCFGFR1MEN1
SCHEMBL4417045 0.76 KDR (0.53) KITPDGFRASRCLCKFLT1
SCHEMBL10043847 0.74 SYK (0.59) KITSRCLCKFLT1LYN
SCHEMBL5065289 0.74 BRAF (0.66) PDGFRASRCLCKFYNSYK
SCHEMBL20852497 0.73 KIT (0.51) KITPDGFRASRCLYNFGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101553232-A Kinase inhibitors useful for the treatment of proliferative diseases DECIPHERA PHARMACEUTICALS LLC (US) 2009-10-07 CN claimed
CN-101553232-A Kinase inhibitors useful for the treatment of proliferative diseases DECIPHERA PHARMACEUTICALS LLC (US) 2009-10-07 CN disclosed